BAY 1024767 blocks androgen receptor mutants found in castration-resistant prostate cancer patients
Authors:
Open Access
- 9 January 2016
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 7 (5) , 6015-6028
Abstract
BAY 1024767 blocks androgen receptor mutants found in castration-resistant prostate cancer patientsKeywords
This publication has 53 references indexed in Scilit:
- An F876L Mutation in Androgen Receptor Confers Genetic and Phenotypic Resistance to MDV3100 (Enzalutamide)Cancer Discovery, 2013
- A Clinically Relevant Androgen Receptor Mutation Confers Resistance to Second-Generation Antiandrogens Enzalutamide and ARN-509Cancer Discovery, 2013
- Overcoming mutation-based resistance to antiandrogens with rational drug designeLife, 2013
- The Impact of Point Mutations in the Human Androgen Receptor: Classification of Mutations on the Basis of Transcriptional ActivityPLOS ONE, 2012
- Intratumoral De Novo Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 InhibitorsCancer Research, 2011
- Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptorProceedings of the National Academy of Sciences, 2010
- Integrative Genomic Profiling of Human Prostate CancerCancer Cell, 2010
- Systematic Structure-Function Analysis of Androgen Receptor Leu701 Mutants Explains the Properties of the Prostate Cancer Mutant L701HJournal of Biological Chemistry, 2010
- Structural basis for antagonism and resistance of bicalutamide in prostate cancerProceedings of the National Academy of Sciences, 2005
- Dunning R3327-G prostate carcinoma of the rat: an appropriate model for drug evaluationJournal of Cancer Research and Clinical Oncology, 1992